Research and Markets


Printer Friendly

Printed from http://www.researchandmarkets.com/reports/368231


Point of Care Diagnostics Market in the US: Opportunities and Challenges


Description: Diagnosing at the point of care offers many advantages: increased patient empowerment, improved clinical outcomes, and fewer days at the hospital. As a result, physicians are ordering more point of care tests and companies are racing to meet growing demand. Their efforts are made easier by improved knowledge of diseases and drug responses at the molecular level and improved technologies that enable simpler, more self-contained testing. These trends, according to a new report are expected to drive double-digit growth over the next five years. According to this new report, the market is expected to grow from $5.5 billion in 2005 to as much as $7.5 billion in 2010.

But this opportunity is not without challenges. Point of care diagnostics is a highly competitive and challenging marketplace, with more than 50 companies and 40 types of tests, not to mention regulatory guidelines, reimbursement challenges, and information technology infrastructure needs. Moreover, point of care testing is inherently more expensive than central laboratory-based testing on a per test basis, resulting in intense price pressure. Success in this market depends on a detailed understanding of the trends, the unmet needs, the technologies, and the prices.

This new report is the ideal tool for planning for success. The comprehensive analysis of the US market is based on

(1) a proprietary comprehensive database of tests,
(2) discussions with clinicians,
(3) detailed assessments of current and emerging technologies, and
(4) CDC, FDA, and professional organizational guidelines and publications.

Twenty-one figures, 32 tables, and profiles of 57 companies present the information in a simple and readily accessible manner. This report is the go-to tool for those wishing to enter and those wishing to stay current in this dynamic market.


Contents: EXECUTIVE SUMMARY

INTRODUCTION

Figure 1 - Examples Of Tests Performed In Various Point Of Care Settings
Figure 2 - Logic Tree For Determining If A Diagnostic Is Appropriate For Use As A POCT

Technologies Used in Point of Care Testing

Introduction

Figure 3 - A Variety Of Technologies Are Used In POC Testing.
Immunoassays
Figure 4 - Solid Phase Or Dipstick Immunoassay
Figure 5 - Agglutination Test
Figure 6 - Lateral Flow Test
Enzymatic assays
Figure 7 - Example Of An Enzymatic Reaction Used To Measure Glucose
Chemical measurements
Amperometric methods-electrodes
Figure 8 - Clark-Type Oxygen Sensing Electrode

INFORMATION TECHNOLOGY AND DATA INTEGERATION

INFORMATION TECHNOLOGY AND DATA MANAGEMENT COMPANIES SERVING THE POINT OF CARE MARKET

REGULATORY COMPLIANCE FOR POINT OF CARE TESTING

POINT OF CARE TESTS ON MARKET BY APPLICATION

Asthma
Theophylline Testing
Table 1 - POC Theophylline Test
Blood Gas Measurements
Blood Electrolyte Testing
Hemoglobin
Table 2 - POC Blood Gas, Electrolyte And Hemoglobin Tests
Cardiovascular Disease
BNP- B -Type Natriuretic Peptide, a Biochemical Marker for Heart Failure
Table 3 - Point of Care Tests for BNP
CK-MB
Troponins
Myoglobin
Table 4 - POC Tests for Markers Associated with Acute Cardiac Syndrome
Cholesterol and Triglycerides
Table 5 - POC Tests to Measure Cholesterol and Lipids
Kidney Disease
Urinary albumin
Table 6 - Point of Care Tests for Microalbuminuria
Diabetes
Glucose Monitoring
Table 7 - Bedside Glucose Monitors
Glycosylated Hemoglobin (glycohemoglobin, hemoglobin A1c)
Table 8 - POC HbA1c Tests
Urine and Blood Ketones
Table 9 - POC Tests for Blood Ketones
Hemostasis
aPTT-Activated Partial Thromboplastin Time Test
ACT-Activated Clotting Time Test
PT-Prothrombin Time, International Normalized Ratio
Table 10 - POC Blood Clotting Tests
D-dimer
Table 11 - POC D-Dimer Tests
Platelet Function Tests
Table 12 - POC Platelet Function Tests
Infectious Disease
Lyme Disease
Table 13 - POC Test for Detection of Borrelia burgdorferi
Chlamydia
Table 14 - POC Tests for Detection of Chlamydial Infection
Clostridium difficile
Table 15 - POC Tests for Detection of Clostridium difficile
H. pylori
Table 16 - POC Tests for Detection of H. Pylori
HIV
Table 17 - POC Tests for HIV
Infectious Mononucleosis
Table 18 - POC Tests for Infectious Mononucleosis
Infectious Vaginitis
Table 19 - POC Tests for Infectious Vaginitis
Influenza
Table 20 - POC Tests for Influenza
Legionella pneumophila
Table 21 - POC Test for Legionella pneumophila
RSV
Table 22 - POC Tests for RSV
Streptococcal Infections-StrepA
Table 23 - POC Tests for Streptococcus pyogenes
Trichomonas Vaginitis
Table 24 - POC Test for Trichomonas vaginitis
Inflammatory disease
CRP-C-reactive Protein
Table 25 - POC Tests for C-Reactive Protein
Perinatal, Neonatal care
Hyperbilirubinemia
Table 26 - POC Bilirubin Tests
ROM
Table 27 - POC Test for Ruptured Fetal Membranes
Oncology
Alpha-fetoprotein (AFP) Blood Test
Table 28 - POC Test for Alpha-fetoprotein
PSA
Table 29 - POC Tests for Prostate Specific Antigen
NMP22
Table 30 - POC Tests for NMP22
Fecal Occult Blood
Table 31 - POC Tests for Fecal Occult Blood


TRENDS AND UNMET NEEDS
MARKET DRIVERS
MARKET MODELS

Aggregate Market

Figure 9 - Numbers of Companies with Offerings

Figure 10 - Numbers of Point of Care Tests Offered by Indication
Market Sizes and Trends

Figure 11 - Market Sizes for POCT Addressing Cardiovascular Health, Inflammation, Asthma
Figure 12 - Market Sizes for POCT Addressing Infectious Diseases
Figure 13 - Market Sizes for POCT in Support Of Diabetes Treatment
Figure 14 - Market Sizes for POCT Assisting in The Diagnosis Of Cancer
Figure 15 - Market Sizes For Instrumentation Supporting POCT

Test Costs

Figure 16 - List Prices for POCTs Addressing Infectious Disease
Figure 17 - List Prices for POCT Addressing Cardiovascular Disease, Hemostasis And Inflammatory Disease
Figure 18 - List Prices for POCT Aiding In The Management Of Diabetes.
Figure 19 - List prices of Instrumentation Supporting Cardiovascular Disease, Hemostasis And Inflammatory Disease POCT
Figure 20 - List Prices for POC Instruments And Monitors Aiding In The Management Of Diabetes.

Incidence and Prevalence of Indications Served by Point of Care Testing

Figure 21 - US Incidence Of Acute Disease Indications Supported By POCT
Figure 22 - US Prevalence Of Chronic Diseases Supported By POC Diagnostics


APPENDIX METHODOLOGY

Author Credentials
Market Model
Sources

APPENDIX II LIST OF 2006 CLIA-WAIVED TESTS

Hematology
Urinalysis/Clinical Microscopy
Chemistry
Toxicology
Bacteriology
Virology
Immunology

Appendix III Company Profiles

Abbott Diagnostics
Abaxis
Accumetrics
AccuTech, LLC
AGEN Biomedical Limited
Avox Systems, Inc
Axis-Shield PoC
Bayer HealthCare Diagnostics Division
Beckman Coulter
BD (Becton, Dickinson and Company)
Binax
Bio-Rad Laboratories
Biosite
Cholestech
Cortez Diagnostics, Inc.
Dade Behring
Diagnostic Chemicals Limited
Dräger Medical AG & Co. KG
Farallon Medical, Inc.
Fujiribio Diagnostics
Genzyme Diagnostics
Germaine Laboratories, Inc.
Helena Laboratories Corporation
HemoCue Inc.
HemoSense, Inc.
Hypoguard USA, Inc.
Immunostics, Inc.
Instrumentation Laboratory Company
International Technidyne (ITC)
Inverness Medical Innovations Inc
JANT PHARMACAL Corporation
LifeScan, Inc
Medtronic Diabetes
N-Dia Inc.
Nova Biomedical Corporation
OraSure Technologies, Inc.
Osmetech, Inc.
Orion Diagnostica
PerMaxim
Polymedco Inc
Polymer Technology Systems, Inc. (PTS)
Princeton BioMeditech
Provalis plc
Quidel Corporation
Radiometer America Inc.
Reichert, Inc.
Remel
Respironics, Inc.
Response Biomedical Corp
Roche Diagnostics
SA Scientific, Ltd.
Serim Research Corporation
Sienco, Inc.
Stanbio Laboratory
Teco Diagnostics
Trinity Biotech Plc
ZymeTx, Inc.


Companies Mentioned Abbott Diagnostics Abaxis Accumetrics AccuTech, LLC AGEN Biomedical Limited Avox Systems, Inc Axis-Shield PoC Bayer HealthCare Diagnostics Division Beckman Coulter BD (Becton, Dickinson and Company) Binax Bio-Rad Laboratories Biosite Cholestech Cortez Diagnostics, Inc. Dade Behring Diagnostic Chemicals Limited Dräger Medical AG & Co. KG Farallon Medical, Inc. Fujirebio Diagnostics Genzyme Diagnostics Germaine Laboratories, Inc. Helena Laboratories Corporation HemoCue Inc. HemoSense, Inc. Hypoguard USA, Inc. Immunostics, Inc. Instrumentation Laboratory Company International Technidyne (ITC) Inverness Medical Innovations Inc JANT PHARMACAL Corporation LifeScan, Inc Medtronic Diabetes N-Dia Inc. Nova Biomedical Corporation OraSure Technologies, Inc. Osmetech, Inc. Orion Diagnostica PerMaxim Polymedco Inc Polymer Technology Systems, Inc. (PTS) Princeton BioMeditech Provalis plc Quidel Corporation Radiometer America Inc. Reichert, Inc. Remel Respironics, Inc. Response Biomedical Corp Roche Diagnostics SA Scientific, Ltd. Serim Research Corporation Sienco, Inc. Stanbio Laboratory Teco Diagnostics Trinity Biotech Plc ZymeTx, Inc.


Ordering: Order Online - visit http://www.researchandmarkets.com/reports/368231

Order by Fax - using the order form below

Order By Post - print the order form below and send to

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.


Research and Markets Page 1 of 2
Printed 05/09/2008 19:37:40
Fax Order Form

To place an order via fax simply print this form, fill in the information below and fax the completed form to the number at the bottom of this page. If you have any questions please email help@researchandmarkets.com


Order information

Please verify that the product information is correct and select the format you require.

Product Name:
Point of Care Diagnostics Market in the US: Opportunities and Challenges

Web Address:
http://www.researchandmarkets.com/reports/368231

Office Code:
OCHHGLORTTT

Report formats

Please enter the quantity of the report format you require.

Format Quantity Price
Electronic (PDF) - Site License €2,506.00
Hard Copy €2,506.00 + EUR€ 50.00 Shipping/Handling *

* Shipping/Handling is only charged once per order.


Contact information

Please enter all the information below in BLOCK CAPITALS.

First Name:   Last Name:  
Email Address:
Job Title:
Organisation:
Address:
City:
Postal/Zip Code:
Country:
Phone Number:
Fax Number:


Please fax this form to:
(646) 607-1907 or (646) 964-6609 - From USA
+353 1 481 1716 or +353 1 653 1571 - From Rest of World

Research and Markets Page 2 of 2
Printed 05/09/2008 19:37:40


Payment information

Please indicate the payment method you would like to use by selecting the appropriate box.

 Pay by Credit Card:
American Express
Diners Club
Master Card
Visa
Cardholder Name:
Expiry Date: /
Card Number:
CVV Security Code:
Issue Date: /   (Diners Club only)


 Pay by Check:
Please post the check, accompanied by this form, to:

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.


 Pay by Wire Transfer:
Please transfer funds to:

Account number: 83313083
Sort code: 98-53-30
Swift code: ULSBIE2D
IBAN number: IE78ULSB98533083313083
Bank Address: Ulster Bank,
27-35 Main St,
Blackrock,
Co. Dublin,
Ireland.


If you have a Marketing Code please enter it below:

Marketing Code:


Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at http://www.researchandmarkets.com/info/terms.asp



Please fax this form to:
(646) 607-1907 or (646) 964-6609 - From USA
+353 1 481 1716 or +353 1 653 1571 - From Rest of World